Prime Minister Dr. Mwigulu Nchemba has called for stronger regional cooperation across Africa to fight cancer, stressing that no country can win the battle alone.
Speaking on Thursday while representing President Dr. Samia Suluhu Hassan at the 30th anniversary of the Ocean Road Cancer Institute, Dr. Mwigulu emphasized the importance of collaboration in research, training, expert exchange, technology sharing, and best practices.
“Tanzania is ready to partner with all African countries. Through the Ocean Road Cancer Institute, we will continue to serve as a hub for regional and continental cooperation in cancer control,” he said.
Dr. Mwigulu also highlighted that research and scientific publications from the Institute have informed policy and improved cancer management locally and internationally.
He announced that the government has allocated TZS 18.5 billion for the introduction of PET-CT Scan and Cyclotron services, aimed at improving early diagnosis and treatment.
The Prime Minister also urged the Ministry of Health to develop a comprehensive strategy to reduce new cancer cases, citing WHO projections that cancer rates in Africa could increase by more than 60% by 2030.
“The Ministry must act now to reduce new cancer cases to protect our people, economy, and national wellbeing,” he said.
Dr. Mwigulu further outlined the government’s ongoing efforts to strengthen cancer care, including wider access to early detection services for cervical, breast, prostate, and colorectal cancers, even at primary healthcare levels.
Minister of Health Mohamed Mchengerwa reinforced the message, noting that the fight against cancer is a national priority, not just a personal or family matter.
“Health is not only a service but a right and a matter of dignity. The government is committed to providing accessible, timely, and equitable cancer care, reflecting President Samia’s vision of health as a national agenda,” he said.
Tanzania aims to reduce cancer-related deaths by at least 30% by 2030, positioning the country as a regional leader in cancer research, treatment, and collaboration.